|
WO2020113237A1
|
|
Next-generation molecular profiling
|
|
AU2018240195A1
|
|
Genomic stability profiling
|
|
AU2016201396A1
|
|
System and method for determining individualized medical intervention for a disease state
|
|
EP3265079A1
|
|
Molecular profiling for cancer
|
|
AU2015210886A1
|
|
Molecular profiling of immune modulators
|
|
US2014156199A1
|
|
Molecular profiling of tumors
|
|
AU2013355260A1
|
|
Molecular profiling for cancer
|
|
US2014018254A1
|
|
Theranostic and diagnostic methods using sparc and hsp90
|
|
CA2838736A1
|
|
Molecular profiling for cancer
|
|
AU2011352167A1
|
|
Molecular profiling for cancer
|
|
EP2494077A2
|
|
Molecular profiling for personalized medicine
|
|
CA2751888A1
|
|
Molecular profiling of tumors
|
|
GB0920030D0
|
|
miRNA expression in the characterisation and classification of cancer
|
|
WO2010033597A2
|
|
Methods for detecting overexpression of sparc and therapeutic and diagnostic methods relating to same
|
